Friday, Jul 24, 2026 The claims desk. Receipts included. POWERED BY LENZ ↗
IsThis

HEALTH

The Claim

The study described in PubMed Central article PMC12952596 was a randomized clinical trial with a sample of 212 adults.

Verified by Lenz ·

The Short Version

The study is well-supported as a randomized clinical trial in adult cancer patients, but the specific claim that it had a sample of 212 adults is not directly confirmed in the evidence provided. Multiple authoritative records identify the article and its trial design. However, none of the cited excerpts actually quote the participant count, and planned enrollment may differ from the final analyzed sample.

Caveats

  • The number 212 is not directly quoted in the provided PubMed, PMC, or publisher excerpts, so the sample-size portion remains unverified.
  • Clinical trial registry numbers and published sample sizes can differ because enrollment, exclusions, and analysis populations are not always the same.
  • One background source disputed the live PMC record, but multiple higher-authority records link the article to PMC12952596; the stronger uncertainty is the exact participant count, not the article identity.

The Receipts

  1. PMC12952596

    PubMed Central

  2. PubMed Central overview

    NCBI Bookshelf

  3. Randomized clinical trial in cancer patients shows immune metabolic effects exerted by formulated bioactive phenolic diterpenes with potential clinical benefits

    PubMed

  4. Study design

    PubMed Central

  5. Overview of clinical study designs

    PubMed Central

  6. Observational and interventional study design types; an overview

    Biochemia Medica

  7. Efficacy of Early Intensive Blood Pressure Management After Thrombectomy: Protocol for a Randomized Controlled Clinical Trial (IDENTIFY)

    PubMed

  8. Randomized clinical trial in cancer patients shows immune metabolic effects exerted by formulated bioactive phenolic diterpenes with potential clinical benefits

    Frontiers in Immunology

  9. Study Design

    Penn Medicine Clinical Research

  10. Study Details | NCT00916409 | Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme

    ClinicalTrials.gov

+ 14 more sources — see the full list on Lenz

Filed Under

PMC12952596PubMed Central